CML
Medical abbreviation · Hematology and Oncology
| Stands for | Chronic myeloid leukemia |
|---|---|
| Categories | Medical |
CML stands for Chronic myeloid leukemia, a hematology and oncology abbreviation.
Myeloproliferative neoplasm driven by the BCR-ABL1 fusion gene, causing a very high white blood cell count, often with an enlarged spleen, fatigue and night sweats. Without treatment it progresses from a chronic phase to an accelerated and blast phase resembling acute leukemia.
Example: WBC 180,000 with basophilia and splenomegaly; BCR-ABL positive: chronic-phase CML, starting imatinib.
Usage notes
Tyrosine kinase inhibitors, beginning with imatinib in 2001, turned CML into a manageable chronic condition, and most patients diagnosed in the chronic phase now have near-normal life expectancy. Response is monitored with quantitative PCR of BCR-ABL every few months. About half of patients who achieve deep, durable responses can stop therapy without relapse. Also called chronic myelogenous leukemia.
Related abbreviations
More hematology and oncology abbreviations
- CAR-T – Chimeric antigen receptor T-cell therapy
- CAT – Cancer-associated thrombosis
- CEA – Carcinoembryonic antigen
- chemo – Chemotherapy
- CHOP – Cyclophosphamide, hydroxydaunorubicin (doxorubicin), Oncovin…
- CLL – Chronic lymphocytic leukemia
- CR – Complete response
- CRAB – Hypercalcemia, renal insufficiency, anemia, bone lesions
- CRS – Cytokine release syndrome
- Cryo – Cryoprecipitate
- CTCAE – Common Terminology Criteria for Adverse Events
- ctDNA – Circulating tumor DNA
See all 144 hematology and oncology abbreviations →
This entry is for general education and is not medical advice. Abbreviation use varies between institutions; always confirm in context.